Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a4afb11b9038232a630fc22a300b2717 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-177 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-366 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
filingDate |
2016-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40a8652bc1b1cf1ff02e455f04cc69ce http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99d3180f76892aaa8fa7893b5042c924 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75ae4a2e9b9c167818a340cdf3ea5b77 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c634cb8f7ee761bc8a1b2154abfe5b6a |
publicationDate |
2016-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2016104803-A |
titleOfInvention |
Medicine for treatment and / or improvement of sepsis |
abstract |
Disclosed is a medicament for effectively treating and / or improving sepsis in patients with severe sepsis. A patient with severe sepsis, which is a medicament for the treatment and / or improvement of sepsis containing thrombomodulin as an active ingredient, wherein the international standard ratio (INR) value of the plasma sample of the patient is greater than 1.4. A medicament for administration to patients with severe sepsis having one or more organ disorders and administered at a dose of 6 mg of thrombomodulin when administered to a patient weighing more than 100 kg. [Selection figure] None |
priorityDate |
2011-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |